Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
27.89
Dollar change
-2.02
Percentage change
-6.75
%
IndexRUT P/E- EPS (ttm)-2.73 Insider Own14.35% Shs Outstand49.34M Perf Week5.32%
Market Cap1.38B Forward P/E- EPS next Y-2.95 Insider Trans-9.84% Shs Float42.26M Perf Month54.77%
Income-95.93M PEG- EPS next Q-0.73 Inst Own75.51% Short Float16.71% Perf Quarter126.01%
Sales21.99M P/S62.58 EPS this Y21.48% Inst Trans0.29% Short Ratio6.83 Perf Half Y65.62%
Book/sh7.72 P/B3.61 EPS next Y-13.10% ROA-29.90% Short Interest7.06M Perf Year43.99%
Cash/sh6.48 P/C4.30 EPS next 5Y- ROE-33.00% 52W Range9.44 - 35.61 Perf YTD37.66%
Dividend Est.- P/FCF- EPS past 5Y-49.09% ROI-28.05% 52W High-21.69% Beta2.88
Dividend TTM- Quick Ratio18.07 Sales past 5Y-1.46% Gross Margin74.42% 52W Low195.44% ATR (14)2.00
Dividend Ex-Date- Current Ratio18.07 EPS Y/Y TTM17.81% Oper. Margin-477.24% RSI (14)57.82 Volatility5.66% 8.11%
Employees140 Debt/Eq0.05 Sales Y/Y TTM1014.45% Profit Margin-436.30% Recom1.00 Target Price49.56
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q69.41% Payout- Rel Volume0.42 Prev Close29.91
Sales Surprise150.46% EPS Surprise60.86% Sales Q/Q3940.80% EarningsNov 09 AMC Avg Volume1.03M Price27.89
SMA206.46% SMA5026.97% SMA20062.86% Trades Volume438,854 Change-6.75%
Date Action Analyst Rating Change Price Target Change
Feb-07-24Resumed Goldman Buy $81
Oct-26-23Initiated RBC Capital Mkts Outperform $25
Oct-24-23Initiated Cantor Fitzgerald Overweight $32
Oct-18-23Upgrade Leerink Partners Market Perform → Outperform $24
Jul-05-23Initiated Chardan Capital Markets Buy $30
Jan-30-23Initiated BMO Capital Markets Outperform $50
Nov-18-22Initiated H.C. Wainwright Buy $36
Nov-15-22Upgrade Goldman Neutral → Buy $12 → $68
Aug-12-22Downgrade SVB Leerink Outperform → Mkt Perform $12
Jun-22-22Initiated Jefferies Buy $22
Feb-12-24 08:00AM
Feb-08-24 03:05AM
Feb-06-24 11:27PM
Feb-05-24 04:05PM
02:50PM
12:36PM Loading…
12:36PM
Feb-03-24 05:00PM
Jan-29-24 08:00AM
Jan-25-24 10:04PM
Jan-23-24 08:00AM
Jan-19-24 12:00PM
Jan-11-24 10:00AM
Jan-09-24 05:02AM
Jan-06-24 05:02AM
05:02AM
08:00AM Loading…
Jan-04-24 08:00AM
Jan-03-24 08:01AM
Dec-21-23 08:00AM
Dec-04-23 08:00AM
Nov-15-23 08:00AM
Nov-09-23 04:19PM
Nov-01-23 04:00PM
Oct-30-23 08:00AM
Oct-26-23 09:56AM
Oct-25-23 08:00AM
Oct-23-23 08:00AM
Sep-12-23 04:05PM
Sep-07-23 04:05PM
08:00AM
Aug-09-23 06:15PM
04:05PM Loading…
04:05PM
08:22AM
Jul-29-23 12:00PM
Jul-17-23 04:05PM
Jul-10-23 07:30PM
Jun-08-23 09:53AM
Jun-07-23 04:10PM
Jun-01-23 08:00AM
May-24-23 08:00AM
May-13-23 08:27AM
May-12-23 06:02PM
06:02PM
May-11-23 08:00AM
May-10-23 05:55PM
04:05PM
May-09-23 04:05PM
08:25AM
May-08-23 04:05PM
06:27AM
May-04-23 09:04PM
04:08PM
Apr-27-23 04:29PM
07:00AM
Apr-24-23 08:00AM
08:00AM
Apr-14-23 04:23AM
Apr-13-23 08:00AM
Apr-12-23 08:21AM
Mar-24-23 06:30AM
Mar-22-23 08:09AM
Mar-15-23 05:45PM
04:05PM
Mar-02-23 05:41AM
Feb-23-23 11:33AM
Feb-22-23 04:05PM
Feb-16-23 04:05PM
Feb-08-23 04:05PM
Feb-02-23 04:05PM
Jan-30-23 12:54PM
Jan-09-23 09:00AM
Dec-01-22 08:26PM
Nov-21-22 04:05PM
Nov-20-22 05:39AM
Nov-17-22 10:36AM
Nov-14-22 02:07PM
07:30AM
Nov-10-22 04:05PM
05:08AM
Nov-09-22 04:05PM
Nov-03-22 09:45AM
06:30AM
Oct-26-22 04:05PM
Sep-27-22 04:10PM
Sep-23-22 06:02AM
Sep-20-22 04:15PM
Aug-12-22 11:20AM
Aug-11-22 05:15PM
04:03PM
Jun-28-22 04:23PM
Jun-02-22 04:02PM
May-14-22 08:19AM
May-12-22 05:35PM
04:01PM
May-09-22 05:55PM
May-05-22 04:02PM
03:00PM
Apr-04-22 04:02PM
Mar-30-22 11:49AM
Mar-28-22 04:02PM
Feb-22-22 04:02PM
4D Molecular Therapeutics, Inc. operates as a clinical stage biotherapeutics company, which engages in the design, development, and commercialization of transformative gene therapeutic products for serious unmet medical conditions. It offers products for ophthalmology, cardiology, and pulmonology. The company was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bizily ScottChief Legal OfficerFeb 16Option Exercise7.601,75013,2953,487Feb 21 05:41 PM
Bizily ScottChief Legal OfficerFeb 16Sale27.671,75048,4221,737Feb 21 05:41 PM
Bizily ScottChief Legal OfficerFeb 08Option Exercise10.186,24463,5864,653Feb 12 09:04 PM
Kirn DavidChief Executive OfficerFeb 08Sale27.1392,0012,495,8221,059,153Feb 12 08:22 PM
Bizily ScottChief Legal OfficerFeb 08Sale27.506,244171,7101,737Feb 12 09:04 PM
Kim Robert YoungChief Medical OfficerFeb 05Option Exercise15.2924,000366,84013,595Feb 07 08:32 PM
Kim Robert YoungChief Medical OfficerFeb 05Sale30.0524,552737,7881,043Feb 07 08:32 PM
Kirn DavidChief Executive OfficerJan 23Sale18.415,696104,8511,151,154Jan 25 04:59 PM
Kirn DavidChief Executive OfficerJan 05Sale19.5728,237552,4781,156,850Jan 08 04:19 PM
VIKING GLOBAL INVESTORS LP10% OwnerJan 04Sale19.53540,00010,546,2004,247,914Jan 05 05:44 PM
Kirn DavidChief Executive OfficerJan 04Sale20.3140,732827,2021,185,087Jan 08 04:19 PM
Kirn DavidChief Executive OfficerDec 18Sale18.134,70285,2431,225,819Jan 08 04:19 PM
Kirn DavidChief Executive OfficerDec 15Sale17.2728,632494,4321,230,521Jan 08 04:19 PM
Bizily ScottChief Legal and HR OfficerJun 08Option Exercise8.043,75030,1505,487Jun 12 06:23 PM
Bizily ScottChief Legal and HR OfficerJun 08Sale20.853,75078,1881,737Jun 12 06:23 PM
Bizily ScottChief Legal and HR OfficerJun 01Option Exercise6.491,87512,1693,984Jun 06 07:23 PM
Bizily ScottChief Legal and HR OfficerJun 01Sale18.312,24741,1431,737Jun 06 07:23 PM
Moretti August JChief Financial OfficerMay 15Option Exercise9.413,00028,23011,045May 16 08:52 PM
VIKING GLOBAL INVESTORS LP10% OwnerMay 09Buy16.00850,00013,600,0004,787,914May 11 05:50 PM
Chacko JacobDirectorApr 21Option Exercise9.415,00047,0505,000Apr 25 06:43 PM
Bizily ScottChief Legal and HR OfficerApr 21Option Exercise8.043,75030,1505,859Apr 25 06:44 PM
Chacko JacobDirectorApr 21Sale20.055,000100,2700Apr 25 06:43 PM
Bizily ScottChief Legal and HR OfficerApr 21Sale20.003,75075,0002,109Apr 25 06:44 PM
Bizily ScottChief Legal and HR OfficerMar 01Option Exercise6.491,87512,1694,357Mar 03 06:16 PM
Bizily ScottChief Legal and HR OfficerMar 01Sale19.302,24843,3862,109Mar 03 06:16 PM